Active Ingredient: CILASTATIN SODIUM; IMIPENEM
Proprietary Name: IMIPENEM AND CILASTATIN
Dosage Form; Route of Administration: POWDER; INTRAVENOUS
Strength: EQ 500MG BASE/VIAL;500MG/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A207594
Product Number: 001
Approval Date: Dec 12, 2019
Applicant Holder Full Name: HQ SPECIALTY PHARMA CORP
Marketing Status:
Prescription
Patent and Exclusivity Information